Trials / Completed
CompletedNCT01214317
Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis
Study of Combinative Effect of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Patients With Aggressive Multiple Sclerosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Isfahan University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effect of combinative induction therapy with mitoxantrone and plasmapheresis versus induction therapy with mitoxantrone alone in cases of aggressive multiple sclerosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | plasmapheresis | 3 courses of plasmapheresis are performed before mitoxantrone injection in first 3 months to investigate the efficacy of plasmapheresis in comparison with the other arm that are only treated with mitoxantrone |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2012-01-01
- Completion
- 2012-02-01
- First posted
- 2010-10-05
- Last updated
- 2020-09-16
- Results posted
- 2020-09-16
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01214317. Inclusion in this directory is not an endorsement.